| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/08/1997 | US5618789 Functional human factor VIII |
| 04/08/1997 | US5618788 Preparation of functional human factor VIII and pharmaceutical treatment therewith |
| 04/08/1997 | US5618787 Cyclic peptide antifungal agents |
| 04/08/1997 | US5618786 Aerosolization of protein therapeutic agent |
| 04/08/1997 | US5618785 Antiischemic agents, antitumor agents, antiarthritic agents |
| 04/08/1997 | US5618724 Antibiotics GE 37468 A, B and C |
| 04/08/1997 | US5618717 DNA encoding human AlkB |
| 04/08/1997 | US5618715 Pure nucleotide sequence encoding oncostatin m |
| 04/08/1997 | US5618713 Mutants of human antithrombin III |
| 04/08/1997 | US5618712 Purified, isolated recombinant dna molecule coding for human lysozyme |
| 04/08/1997 | US5618710 Resistance to exogenous proteolysis |
| 04/08/1997 | US5618700 IL-6 specific monoclonal antibodies, hybridomas therefor and methods of making and using same |
| 04/08/1997 | US5618698 Growing host cells transformed or transfected with specified isolated dna sequence, isolating erythropoietin product |
| 04/08/1997 | US5618696 Culture product polypeptide enzyme inhibitor |
| 04/08/1997 | US5618695 DNA encoding HEM-1, a gene expressed by sclerosing hemangioma cells |
| 04/08/1997 | US5618691 Recombinant DNA encoding a eukaryotic tyrosine kinase target protein |
| 04/08/1997 | US5618677 Human brain sodium dependent inorganic phosphate cotransporter assay |
| 04/08/1997 | US5618675 Exposing sample to a specific polypeptide which binds lipopolysaccharide, detecting binding; useful for diagnosis of gramnegative sepsis, endotoxin shock or disseminated intravascular coagulation |
| 04/08/1997 | US5618663 Device for producing a supernatant of activated thrombocytes, method for implementing the device and supernatant obtained |
| 04/08/1997 | US5618564 Composition for the treatment of helicobacter pylori infection |
| 04/08/1997 | US5618553 Contacting localized region of eye with polymer implant having reversibly associated modulating agent which is released at rate such that target cells are primarily affected |
| 04/08/1997 | US5618544 Method of decreasing cutaneous senescence |
| 04/08/1997 | US5618543 Composition and method for reducing snoring and respiratory problems |
| 04/08/1997 | US5618542 Vaccines comprising antigenic polypeptides of Taenia ovis |
| 04/08/1997 | US5618541 Vaccine against Neisseria meningitidis infections |
| 04/08/1997 | US5618540 Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified state |
| 04/08/1997 | US5618534 Isolated antigen endo glyx-1 |
| 04/08/1997 | US5618533 Flagellin-based polypeptides for the diagnosis of lyme disease |
| 04/08/1997 | US5618532 Dirofilaria immitis Gp29 proteins and uses thereof |
| 04/08/1997 | US5618531 Method for increasing the viability of cells which are administered to the brain or spinal cord |
| 04/08/1997 | US5618528 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
| 04/03/1997 | WO1997012246A1 Tumour-specific p450 protein |
| 04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 04/03/1997 | WO1997012057A1 Chemotherapeutic agents for mycobacterium |
| 04/03/1997 | WO1997012055A1 Product and process to regulate actin polymerization |
| 04/03/1997 | WO1997012054A1 Neutrophil chemotactic lymphokine, and drug and kit for the diagnosis of drug hypersensitive granulocytopenia containing the same |
| 04/03/1997 | WO1997012051A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | WO1997012049A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 04/03/1997 | WO1997012043A2 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 04/03/1997 | WO1997012042A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | WO1997012041A1 SHORT FORMS OF CHEMOKINE β-8 |
| 04/03/1997 | WO1997012040A1 GENE THERAPY WITH MODIFIED p65 PROTEINS |
| 04/03/1997 | WO1997012038A1 Novel peptides useful in enhancement of fsh action |
| 04/03/1997 | WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/03/1997 | WO1997012036A2 Bone stimulating factor |
| 04/03/1997 | WO1997012035A2 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | WO1997012034A1 A modified glutamic acid decarboxylase (gad) |
| 04/03/1997 | WO1997011972A1 Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof |
| 04/03/1997 | WO1997011971A1 Porcine cell interaction proteins |
| 04/03/1997 | WO1997011969A1 Type cc chemokine-like protein |
| 04/03/1997 | WO1997011968A2 A gene associated with liver neoplastic disease |
| 04/03/1997 | WO1997011966A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/03/1997 | WO1997011965A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/03/1997 | WO1997011964A1 Truncated glial cell line-derived neurotrophic factor |
| 04/03/1997 | WO1997011963A1 ANTI-GALα(1,3)GAL ANTIBODY BINDING PEPTIDES |
| 04/03/1997 | WO1997011962A1 Cyclic peptide analogs of somatostatin |
| 04/03/1997 | WO1997011961A1 Peptide derivatives having endothelin receptor antagonistic activity |
| 04/03/1997 | WO1997011960A1 Antagonists of endothelin receptors |
| 04/03/1997 | WO1997011957A1 Conjugates of a polypeptide and a biocompatible polymer |
| 04/03/1997 | WO1997011956A1 IDENTIFICATION OF sel-12 AND USES THEREOF |
| 04/03/1997 | WO1997011720A1 Methods for treating cancers and restenosis with p21 |
| 04/03/1997 | WO1997011718A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/03/1997 | WO1997011717A1 Treatment of chronic progressive renal failure |
| 04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
| 04/03/1997 | WO1997011715A1 Mimicking peptides in cancer therapy |
| 04/03/1997 | WO1997011714A1 Chemokine inhibitor |
| 04/03/1997 | WO1997011713A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 04/03/1997 | WO1997011697A1 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone |
| 04/03/1997 | WO1997011690A2 Inhibitors of regulatory pathways |
| 04/03/1997 | WO1997011689A1 Transdermal matrix system |
| 04/03/1997 | WO1997011687A1 Transdermal matrix system |
| 04/03/1997 | WO1997011684A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | WO1997011682A2 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 04/03/1997 | WO1997011669A2 Mhc-class ii restricted melanoma antigens and their use in therapeutic methods |
| 04/03/1997 | WO1997011655A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| 04/03/1997 | WO1997011607A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | WO1997011601A1 Method for prevention of xenograft rejection by transplant recipients |
| 04/03/1997 | WO1997011598A1 Method for treating hepatitis virus infection |
| 04/03/1997 | WO1997005771A3 Lysosomal proteins produced in the milk of transgenic animals |
| 04/03/1997 | WO1997003198A3 Nucleotide and amino acid sequence and uses thereof |
| 04/03/1997 | WO1997003192A3 Chromosome 1 gene and gene products related to alzheimer's disease |
| 04/03/1997 | WO1997001634A3 Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp) |
| 04/03/1997 | WO1996040948A3 Resistance to viruses and viroids in transgenic plant and animal hosts expressing dsrna-binding protein |
| 04/03/1997 | WO1996039516A3 Targets for breast cancer diagnosis and treatment |
| 04/03/1997 | WO1996038473A3 Antimicrobial cationic peptides |
| 04/03/1997 | CA2233367A1 Short forms of chemokine .beta.-8 |
| 04/03/1997 | CA2233343A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | CA2233297A1 Identification of sel-12 and uses thereof |
| 04/03/1997 | CA2233171A1 Transdermal matrix system |
| 04/03/1997 | CA2233162A1 Transdermal matrix system |
| 04/03/1997 | CA2233138A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/03/1997 | CA2233060A1 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | CA2233040A1 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | CA2233031A1 Gene therapy with modified p65 proteins |
| 04/03/1997 | CA2232950A1 Novel peptides useful in enhancement of fsh action |
| 04/03/1997 | CA2232815A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | CA2232706A1 Chemokine inhibitor |
| 04/03/1997 | CA2231735A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 04/03/1997 | CA2231064A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | CA2230940A1 Emulsion and micellar formulations for the delivery of biologically active substances to cells |